Stock data
Ensysce Biosciences, Inc. (ENSC)
Ensysce Biosciences, Inc. (ENSC) reported revenue of US$5.07M and net income of -US$10.18M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$5.07M | — | -US$10.24M | -US$10.18M | — |
| 2024 | US$5.21M | — | -US$6.73M | -US$7.99M | — |
| 2023 | US$2.23M | — | -US$10.72M | -US$10.63M | — |
| 2022 | US$2.52M | — | -US$24.22M | -US$24.21M | — |
| 2021 | US$3.53M | — | -US$19.87M | -US$29.15M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$1.16M | -US$2.57M | — |
| 2026-03-31 | US$0.96M | -US$3.56M | — |
| 2025-12-31 | US$1.88M | -US$2.77M | — |
| 2025-09-30 | US$0.49M | -US$3.73M | — |
| 2025-06-30 | US$1.37M | -US$1.73M | — |
| 2025-03-31 | US$1.32M | -US$1.95M | — |
| 2024-12-31 | US$1.30M | -US$3.56M | — |
| 2024-09-30 | US$3.42M | US$0.66M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.